AlphaYouCG
Insider selling
Christopher Gibson sold $123K of Recursion Pharmaceuticals, Inc. (RXRX) stock
Christopher Gibson, Dir of Recursion Pharmaceuticals, Inc. (RXRX), sold 40,000 shares of RXRX stock worth $123K, per an SEC Form 4 filed May 27, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on May 22, 2026, 5 days before it was made public.
RXRX has moved +31.9% since the trade date, from $3.01 to $3.97 (Sep 21, 2026 close).
- Traded
- May 22, 2026
- Disclosed
- May 27, 2026
- Filing delay
- 5 days
- Price since
- +31.9%
- Role
- Dir
- Source
- SEC Form 4
More RXRX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.